TrialThe oncologist2021

A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma.

Chun A Changou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.